Managing CVT in Pregnancy: Balancing Risks and the Role of Antithrombotic Prophylaxis
International Journal of Stroke (IJS) shared a post on X:
”Just Accepted!
New systematic review & meta analysis. Results find cerebral venous thrombosis & noncerebral VTE pose substantial risks during pregnancy, particularly in women with prior thrombotic events.”
Read the full article here.
Cerebral venous thrombosis (CVT) is a rare but serious condition that poses heightened risks during pregnancy and the postpartum period, especially in women with prior thrombotic events.
In a new PRISMA guidelines-confirmed meta analysis article ‘Cerebral venous thrombosis during pregnancy and postpartum: A systematic review and meta-analysis‘ published by Xiaoming Zhang et al. in the International Journal of Stroke/Sage Journals, the role of antithrombotic prophylaxis in these groups of patients was discussed.
Current data on CVT incidence, recurrence, and outcomes remain inconsistent, and the protective role of antithrombotic prophylaxis is yet to be clearly defined.
While prophylaxis may reduce risks, it must be balanced against potential maternal and fetal complications.
These findings highlight the urgent need for personalized management strategies and further research to guide evidence-based clinical practice.
Recent scientific advancements in the field of thrombosis posted in Hemostasis Today.
-
Jul 16, 2025, 17:23ISTH 2025 Spotlight: HOPE-B Trial Highlights Sustained Efficacy of Gene Therapy for Hemophilia B
-
Jul 16, 2025, 15:00Together with Dr. Bethany Samuelson Bannow – Let’s Keep Hematology Moving Forward
-
Jul 16, 2025, 14:58Donate Today to Advance Thrombosis Awareness and Research
-
Jul 16, 2025, 14:57ISTH SSC Launches Survey on Antithrombotic Therapy in Brain Tumor Patients
-
Jul 16, 2025, 14:52ASH Expands Access to Educational Resources in LMICs
-
Jul 16, 2025, 11:06Why Pain Feels Different for Everyone - The Guardian
-
Jul 15, 2025, 18:24Time and Severe Hypoperfusion: 2 Threats for Hemorrhagic Transformation in Stroke
-
Jul 15, 2025, 15:48Managing CVT in Pregnancy: Balancing Risks and the Role of Antithrombotic Prophylaxis
-
Jul 15, 2025, 07:37Triple Therapy Breakthrough: Corticosteroids, IVIG, and Platelet Transfusions Transform Management of Critical ITP Bleeding - Blood Journals Portfolio
-
Jul 14, 2025, 18:253 Valuable Takeaways from the ANGEL-REBOOT Trial for ICAS-O Stroke
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 15, 2025, 17:002022 Chemistry Laureate Carolyn Bertozzi Shares Inspiring Advice for Young Scientists
-
Jul 15, 2025, 16:42A 200+ Year Historical Review of Women and Hemophilia: Shifting Perspectives
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems